Charles River Laboratories International (CRL) Assets Average (2010 - 2026)
Charles River Laboratories International (CRL) posted Assets Average of $7.6 billion for Q2 2026, up 2.67% on a QoQ basis from $7.4 billion in Q1 2026, and up 0.79% year-over-year from $7.6 billion in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Assets Average (2010 - 2026) Analysis & Trends
Charles River Laboratories International has reported Assets Average for 17 years, with the latest figure at $7.6 billion in Q2 2026.
- On a quarterly basis, Assets Average rose 0.79% year-over-year to $7.6 billion in Q2 2026; TTM through Jun 2026 was $7.6 billion, a 0.79% increase from a year earlier, with the FY2025 full-year figure at $7.3 billion, down 6.74% from the prior year.
- Assets Average was $7.6 billion for Q2 2026 at Charles River Laboratories International, up from $7.4 billion in the prior quarter.
- The five-year high for Assets Average was $8.2 billion in Q1 2024, with the low at $7.0 billion in Q1 2022.
- Average Assets Average over 5 years is $7.6 billion, with a median of $7.6 billion recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: Assets Average climbed 24.78% in 2022, then declined 7.57% in 2025.
- Over 5 years, Assets Average stood at $7.5 billion in 2022, then advanced by 5.45% to $7.9 billion in 2023, then decreased by 1.71% to $7.8 billion in 2024, then decreased by 5.68% to $7.3 billion in 2025, then climbed by 4.19% to $7.6 billion in 2026.
- The last three Assets Average figures came in at $7.6 billion (Q2 2026), $7.4 billion (Q1 2026), and $7.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 29.78 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 2.09 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 16.36 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 7.63 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.70 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.87 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 1.01 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 30.14 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 14.01 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 5.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 7.63 Bn |
| Mar 28, 2026 | 7.43 Bn |
| Dec 27, 2025 | 7.32 Bn |
| Sep 27, 2025 | 7.54 Bn |
| Jun 28, 2025 | 7.57 Bn |
| Mar 29, 2025 | 7.56 Bn |
| Dec 28, 2024 | 7.77 Bn |
| Sep 28, 2024 | 7.98 Bn |
| Jun 29, 2024 | 8.05 Bn |
| Mar 30, 2024 | 8.17 Bn |
| Dec 30, 2023 | 7.90 Bn |
| Sep 30, 2023 | 7.69 Bn |
| Jul 1, 2023 | 7.74 Bn |
| Apr 1, 2023 | 7.65 Bn |
| Dec 31, 2022 | 7.49 Bn |
| Sep 24, 2022 | 7.46 Bn |
| Jun 25, 2022 | 7.30 Bn |
| Mar 26, 2022 | 7.05 Bn |
| Dec 25, 2021 | 7.04 Bn |
| Sep 25, 2021 | 6.89 Bn |